Drug Regulatory Authority Pakistan (DRAP) has given their first ever approval of a new molecule on indigenous data. Cansino Bio COVID 19 Vaccine has been approved in Feb 2021 for EUA by DRAP after evaluation of interim analysis of >17000 Pakistani subject. Dimension Research has the honor to provide site regulatory, management and monitoring
Dimension Research has organized annual lunch for its Karachi teams at Marriott Hotel Karachi on Saturday, 2nd January 2021. Clinical Research, Patient supports programs teams (UNMOL, Hamqadam, Maseeha and Lantus Aasaan) teams and head office staff participated and enjoyed the luscious lunch. The expanding Dimension family get to know each other and discuss their
Dimension Research team took part in a walk organized by Syed Abdullah Shah Medical Hospital, Sehwan City on Saturday, 28th November 2020. The World Diabetes Day was observed where a seminar was held in which a large number of patients, doctors and paramedical staff participated. Addressing the seminar, Dr. Ahsan Siddiqui advised patients to
Dimension Research has conducted a two days comprehensive training program on “International Conference on Harmonization-Good Clinical Practice” (ICH-GCP) at NIH Islamabad on 2nd and 3rd Sep 2020. Participants of this training were personnel involved in the upcoming land mark COVID 19 Vaccine Phase III study. Maj Gen Aamir Ikram (Executive Director NIH) and the
ISLAMABAD/KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) on Monday gave its approval to the National Institute of Health (NIH) to conduct the Phase III clinical trial of a coronavirus vaccine, making it the first one ever in the country. According to a statement from the NIH, the medical facility has obtained "the formal
Dimension Research has conducted training program on “Pakistan Pharmacovigilance Guidelines & ADR Reporting System” at Prof. Dr. Majid Ali Abidi clinic - The Brain Clinic, Taj Medical Complex, Karachi on Thursday, 6th August 2020. Prof. Dr. Majid Ali Abidi showed his interest to establish ADR reporting system as per national guidelines and to conduct a
Dimension Research has conducted training program on “Pakistan Pharmacovigilance Guidelines & ADR Reporting System” in Department of Psychiatry, Jinnah Postgraduate Medical Centre (JPMC) on Wednesday, 8th July 2020. Professor Dr. Iqbal Afridi Head of Department of Psychiatry JPMC and President Pakistan Psychiatric Society requested DR to conduct a training session in his department and showed interest
As part of Drug Regulatory Authority Pakistan (DRAP) efforts to streamline and develop clinical research activities on ethical and professional grounds. DRAP has rolled out Biostudy Rules 2017 that will serve as basis of conducting clinical research in Pakistan. In line with these guidelines DRAP Pharmacy Services department has initiated an
DR is conducting training on “Adverse Drug Reaction Reporting” with collaboration with KMDC at Community Health Sciences, KMDC. The CEO of Dimension Research Khurram Zaki has briefly described the importance of ADR reporting while the HOD of Community Health Sciences KMDC, has highlighted that it is the core responsibility of doctors to report ADR
He said that KMC cares for its citizen even with its limited resources specially those coming to their Health Care Facilities for treatment. The Mayor Karachi has commended the efforts of Prof. Farhat Ali Jafri, a renowned Public Health expert. KARACHI: Mayor Karachi Wasim Akhtar Tuesday said that the Karachi Metropolitan Corporation (KMC) had
